Cardiovascular comorbidity in rheumatic disease. Does sex matter?;Kardiovaskuläre komorbidität bei rheumatoider arthritis. Spielt das geschlecht eine rolle?

Herz

Volumn 30, Issue 6, 2005, Pages 512-521

  Kung, Margret ^a   Störk, Stefan ^a   Angermann, Christiane E ^a  

^a UNIVERSITY OF WÜRZBURG   (Germany)

Author keywords

Coronary artery disease; Gender; Heart failure; Rheumatic disease; Sex; Sudden cardiac death

Indexed keywords

ANDROGEN; ANTIRHEUMATIC AGENT; BIOLOGICAL MARKER; CHLOROQUINE; CYCLOOXYGENASE 2 INHIBITOR; CYTOKINE; ESTROGEN; GLUCOCORTICOID; PENICILLAMINE; SEX HORMONE;

ARTICLE; ATHEROGENESIS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; COMORBIDITY; CONGESTIVE HEART FAILURE; CORONARY ARTERY DISEASE; CYTOKINE PRODUCTION; DISEASE COURSE; ENVIRONMENTAL FACTOR; EVIDENCE BASED MEDICINE; GENDER; HEART INFARCTION; HORMONE METABOLISM; HUMAN; INCIDENCE; LIFE EXPECTANCY; MORBIDITY; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE; STROKE; SUDDEN DEATH; SYNOVIAL FLUID; TREATMENT OUTCOME;

AGE DISTRIBUTION; ARTHRITIS, RHEUMATOID; CARDIOVASCULAR DISEASES; CLINICAL TRIALS; COMORBIDITY; HUMANS; INCIDENCE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION;

EID: 25444469970     PISSN: 03409937     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00059-005-2717-2     Document Type: Article

References (56)

1. Albano SA, Santana-Sahagun E, Weisman MH. Cigarette smoking and rheumatoid arthritis. Semin Arthritis Rheum 2001;31:146-59.
2. American Heart Association. Heart and Stroke Statistical Update 2005. American Heart Association, Dallas, Texas, 2005 (http://www.americanheart.org/ presenter.jhtml?identifier=3000090).
3. Bijlsma JW, Straub RH, Masi AT, et al. Neuroendocrine immune mechanisms in rheumatic diseases. Trends Immunol 2002;23:59-61.
4. Boers M, Dijkmans B, Gabriel S, et al. Making an impact on mortality in rheumatoid arthritis: targeting cardiovascular comorbidity. Arthritis Rheum 2004;50:1734-9.
5. Castanho VS, Oliveira LS, Pinheiro HP, et al. Sex differences in risk factors for coronary heart disease: a study in a Brazilian population. BMC Public Health 2001;1:3.
6. Cleland JG, Swedberg K, Follath F, et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: Patient characteristics and diagnosis. Eur Heart J 2003;24:442-63.
7. Cutolo M, Lahita RG. Estrogens and arthritis. Rheum Dis Clin North Am 2005;31:19-27, vii.
8. Cutolo M, Straub RH. Polymyalgia rheumatica: evidence for a hypothalamic-pituitary-adrenal axis-driven disease. Clin Exp Rheumatol 2000;18:655-8.
9. Cutolo M, Sulli A, Capellino S, et al. Sex hormones influence on the immune system: basic and clinical aspects in autoimmunity. Lupus 2004;13:635-8.
10. Cutolo M, Villaggio B, Craviotto C, et al. Sex hormones and rheumatoid arthritis. Autoimmun Rev 2002;1:284-9.
11. Cutolo M, Villaggio B, Seriolo B, et al. Synovial fluid estrogens in rheumatoid arthritis. Autoimmun Rev 2004;3:193-8.
12. Doran MF, Pond GR, Crowson CS, et al. Trends in incidence and mortality in rheumatoid arthritis in Rochester, Minnesota, over a forty-year period. Arthritis Rheum 2002;46:625-31.
13. Doria A, Cutolo M, Ghirardello A, et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum 2002;47:202-9.
14. Gabriel SE, Crowson CS, O'Fallon WM. The epidemiology of rheumatoid arthritis in Rochester, Minnesota, 1955-1985. Arthritis Rheum 1999;42:415-20.
15. Gorodeski GI. Update on cardiovascular disease in post-menopausal women. Best Pract Res Clin Obstet Gynaecol 2002;16:329-55.
16. He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med 2001;161:996-1002.
17. Heer T, Schiele R, Schneider S, et al. Gender differences in acute myocardial infarction in the era of reperfusion (the MITRA registry). Am J Cardiol 2002;89:511-7.
18. Hernandez Avila M, Liang MH, Willett WC, et al. Reproductive factors, smoking, and the risk for rheumatoid arthritis. Epidemiology 1990;1:285-91.
19. Iacovino JR. Population-based mortality outcome of rheumatoid arthritis in females. J Insur Med 2002;34:86-8.
20. Johnsen SP, Larsson H, Tarone RE, et al. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study. Arch Intern Med 2005;165:978-84.
21. Kaski JC, Rosano GM, Collins P, et al. Cardiac syndrome X: clinical characteristics and left ventricular function. Long-term follow-up study. J Am Coll Cardiol 1995;25:807-14.
22. Kennedy JW, Killip T, Fisher LD, et al. The clinical spectrum of coronary artery disease and its surgical and medical management, 1974-1979. The Coronary Artery Surgery Study. Circulation 1982;66:III16-23.
23. Komajda M, Lapuerta P, Hermans N, et al. Adherence to guidelines is a predictor of outcome in chronic heart failure: the MAHLER survey. Eur Heart J 2005: in press.
24. Le Bail J, Liagre B, Vergne P, et al. Aromatase in synovial cells from postmenopausal women. Steroids 2001;66:749-57.
25. Lund LH, Mancini D. Heart failure in women. Med Clin North Am 2004;88:1321-45, xii.
26. MacIntyre K, Stewart S, Capewell S, et al. Gender and survival: a population-based study of 201,114 men and women following a first acute myocardial infarction. J Am Coll Cardiol 2001;38:729-35.
27. Maestroni GJ, Sulli A, Pizzorni C, et al. Melatonin in rheumatoid arthritis: a disease-promoting and modulating hormone? Clin Exp Rheumatol 2002;20:872-3.
28. Maradit-Kremers H, Crowson CS, Nicola PJ, et al. Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis:a population-based cohort study. Arthritis Rheum 2005;52:402-11.
29. Maradit-Kremers H, Nicola PJ, Crowson CS, et al. Cardiovascular death in rheumatoid arthritis: a population-based study. Arthritis Rheum 2005;52:722-32.
30. McEntegart A, Capell HA, Creran D, et al. Cardiovascular risk factors, including thrombotic variables, in a population with rheumatoid arthritis. Rheumatology (Oxf) 2001;40:640-4.
31. Mejhert M, Holmgren J, Wandell P, et al. Diagnostic tests, treatment and follow-up in heart failure patients - is there a gender bias in the coherence to guidelines? Eur J Heart Fail 1999;1:407-10.
32. Mosca L, Ferris A, Fabunmi R, et al. Tracking women's awareness of heart disease: an American Heart Association national study. Circulation 2004;109:573-9.
33. Nicola PJ, Maradit-Kremers H, Roger VL, et al. The risk of congestive heart failure in rheumatoid arthritis: a population-based study over 46 years. Arthritis Rheum 2005;52:412-20.
34. Office of Research on Women's Health N. Report of the National Institutes of Health: Opportunities for research on women's health. National Institutes of Health (NIH), Bethesda, Maryland 1992.
35. Park YB, Choi HK, Kim MY, et al. Effects of antirheumatic therapy on serum lipid levels in patients with rheumatoid arthritis: a prospective study. Am J Med 2002;113:188-93.
36. Plutzky J. Inflammatory pathways in atherosclerosis and acute coronary syndromes. Am J Cardiol 2001;88:10K-5K.
37. Ratliff NB, Estes ML, Myles JL, et al. Diagnosis of chloroquine cardiomyopathy by endomyocardial biopsy. N Engl J Med 1987;316:191-3.
38. Raynauld JP. Cardiovascular mortality in rheumatoid arthritis: how harmful are corticosteroids? J Rheumatol 1997;24:415-6.
39. Regitz-Zagrosek V, Lehmkuhl E, Lehmkuhl HB, et al. Gender aspects in heart failure. Pathophysiology and medical therapy. Arch Mal Coeur Vaiss 2004;97:899-908.
40. Rossner S, Lofmark C. Dyslipoproteinaemia in patients with active, chronic polyarthritis. A study on serum lipoproteins and triglyceride clearance (intravenous fat tolerance test). Atherosclerosis 1977;28:41-52.
41. Sanchez-Guerrero J, Villegas A, Mendoza-Fuentes A, et al. Disease activity during the premenopausal and postmenopausal periods in women with systemic lupus erythematosus. Am J Med 2001;111:464-8.
42. Schwartz S. Rheumatoid carditis. JAMA 1977;201:556-8.
43. Shaw LJ, Miller DD, Romeis JC, et al. Gender differences in the noninvasive evaluation and management of patients with suspected coronary artery disease. Ann Intern Med 1994;120:559-66.
44. Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum 1992;35:152-5.
45. Skrifvars B, Laine V, Wegelius O. Sclerosis of the arteries of the extremities in rheumatoid arthritis. Acta Med Scand 1969;186:145-7.
46. Solomon DH, Curhan GC, Rimm EB, et al. Cardiovascular risk factors in women with and without rheumatoid arthritis. Arthritis Rheum 2004;50:3444-9.
47. Solomon DH, Karlson EW, Rimm EB, et al. Cardiovascular morbidity and mortality in women diagnosed with rheumatoid arthritis. Circulation 2003;107:1303-7.
48. Solomon SD, McMurray JJ, Pfeffer MA, et al. Cardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma prevention. N Engl J Med 2005;352:1071-80.
49. Störk S, van der Schouw YT, Grobbee DE, et al. Estrogen, inflammation and cardiovascular risk in women: a critical appraisal. Trends Endocrinol Metab 2004;15:66-72.
50. Straub RH, Cutolo M. Involvement of the hypothalamic-pituitary-adrenal/ gonadal axis and the peripheral nervous system in rheumatoid arthritis: viewpoint based on a systemic pathogenetic role. Arthritis Rheum 2001;44:493-507.
51. Tengstrand B, Carlstrom K, Fellander-Tsai L, et al. Abnormal levels of serum dehydroepiandrosterone, estrone, and estradiol in men with rheumatoid arthritis: high correlation between serum estradiol and current degree of inflammation. J Rheumatol 2003;30:2338-43.
52. Turesson C, O'Fallon WM, Crowson CS, et al. Occurrence of extraarticular disease manifestations is associated with excess mortality in a community based cohort of patients with rheumatoid arthritis. J Rheumatol 2002;29:62-7.
53. Vermes E, Ducharme A, Bourassa MG, et al. Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD). Circulation 2003;107:1291-6.
54. Voigt LF, Koepsell TD, Nelson JL, et al. Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology 1994;5:525-32.
55. Wallberg-Jonsson S, Johansson H, Ohman ML, et al. Extent of inflammation predicts cardiovascular disease and overall mortality in seropositive rheumatoid arthritis. A retrospective cohort study from disease onset. J Rheumatol 1999;26:2562-71.
56. Wluka AE, Cicuttini FM, Spector TD. Menopause, oestrogens and arthritis. Maturitas 2000;35:183-99.